Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

12.12.23	: Pfizer expects to close Seagen deal on Thursday, will create a new oncology division to incorporate company (Market Watch)
12.12.23	Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen (Businesswire)
10.12.23	Marstacimab Phase 3 Data Presented at ASH 2023 Demonstrate Significant Bleed Reduction in Hemophilia A and B (Businesswire)
08.12.23	European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma (Businesswire)
06.12.23	Arvinas, Pfizer Plan To Broaden Development Of Breast Cancer Candidate (Benzinga)
05.12.23	While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer (Benzinga)
04.12.23	Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market (Benzinga)
04.12.23	This Is What Whales Are Betting On Pfizer (Benzinga)
03.12.23	Is Pfizer Stock a Buy Now? (MotleyFool)
01.12.23	Why Pfizer Stock Is Sinking Today (MotleyFool)
01.12.23	Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy (Benzinga)
01.12.23	Pharmakonzern: Pfizer erleidet Rückschlag bei Abnehm-Medikament (Handelsblatt)
01.12.23	Tale Of Two Investigational Obesity Drugs: Altimmune Stock Jumps, While Pfizer Trades Lower (Benzinga)
01.12.23	This Twice Daily Weight Loss Drug Has Adverse Side Effects And Pfizer Wants To Discontinue It (Benzinga)
01.12.23	Pfizer drops plan for twice-daily obesity pill due to side effects (Financial Times)
01.12.23	Pfizer erleidet Rückschlag mit Abnehm-Medikament (Handelszeitung)
01.12.23	: Pfizer says GLP-1 drug met main goal in Phase 2b trial (MarketWatch)
01.12.23	Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity (Businesswire)
30.11.23	How To Make $500 A Month With Pfizer Stock (Benzinga)
26.11.23	Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout? (MotleyFool)
24.11.23	Is Pfizer Stock a Buy Now? (MotleyFool)
21.11.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
20.11.23	18 Analysts Have This to Say About Pfizer (Benzinga)
17.11.23	Aktienempfehlungen konträr: Diese Low-Performer könnten die Top-Aktien 2024 werden (finanzen.ch) Mark Hulbert verrät, welche Low-Performer aus dem laufenden Jahr zu Top-Titeln 2024 werden könnten.» mehr
16.11.23	AbbVie and Pfizer Have 1 Thing in Common: Their Biggest Products Are on the Decline. Time to Sell? (MotleyFool)
02.11.23	Pfizer Highlights Scientific Advances from Growing Hematology Portfolio at American Society of Hematology Annual Meeting (Businesswire)
02.11.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
02.11.23	Die Top 10 der grössten Übernahmen der Geschichte (finanzen.ch) AT&T, Pfizer und die Walt Disney Company haben eines gemeinsam: Sie zahlten hohe Summen, um andere Konzerne zu übernehmen.» mehr
31.10.23	Pfizer Reports Third-Quarter 2023 Results (Businesswire)
26.10.23	Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 (RSS)
26.10.23	Pfizer and BioNTech Announce Positive Topline Data for mRNA-based Combination Vaccine Program Against Influenza and COVID-19 (Businesswire)
20.10.23	FDA Approves PENBRAYA™, the First and Only Vaccine for the Prevention of the Five Most Common Serogroups Causing Meningococcal Disease in Adolescents (Businesswire)
13.10.23	Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance (Businesswire)
12.10.23	U.S. FDA Approves Pfizer’s BRAFTOVI® + MEKTOVI® for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer (Businesswire)
05.10.23	Pfizer Presents New Data at IDWeek 2023 Highlighting Advances in Prevention and Treatment of Certain Respiratory Illnesses and Other Infectious Diseases (Businesswire)
04.10.23	Pfizer Declares Fourth-Quarter 2023 Dividend (Businesswire)
28.09.23	Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine (RSS)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Pfizer Inc Cert.Deposito Arg.Repr. 0.5 Shs

Aktien Top/Flop

Pfizer Peer Group Nachrichten

Meistgelesene Nachrichten